Stockreport

Taysha Gene Therapies Reports First Quarter 2024 Financial Results and Provides Corporate Update [Yahoo! Finance]

Taysha Gene Therapies, Inc.  (TSHA) 
PDF profile and durable response of TSHA-102; enrolled first patient in cohort two (high dose, 1x10 total vg) with dosing scheduled for Q2 2024 Dosed second pediatric pati [Read more]